Remarkably, the mRNA levels of AIM2 were significantly elevated in the male critical (P=0.005) and severe (P=0.04) COVID-19 patients compared to female COVID-19 patients in the same stage (Figure 3B(Fig. 3)). The gene discussed is AIM2; the disease is COVID-19.